Lungs Channel
Topics & Medications
Quicklinks
Related Channels
Ipratropium and Albuterol Inhaler
Using an ipratropium and albuterol inhaler four times a day can help treat symptoms of chronic obstructive pulmonary disease. It combines two medications, which each work in different ways to open up the airways to the lungs. Because the ipratropium and albuterol inhaler is not suitable for everyone, you should talk to your healthcare provider about certain existing medical problems (such as seizures or high blood pressure).
Interested in a Discount on Ipratropium and Albuterol Inhaler?
Enter your email address to see if eMedTV's free DiscountRx service has a program that could help you save on your prescription(s).
Thank you!
Thank you for your interest in DiscountRx from eMedTV. An email has been sent to the address you provided. Please follow the link within that email to see what offers may be available.
The ipratropium and albuterol inhaler (Combivent®) is a prescription medication used to prevent airway spasms (also known as bronchospasms) caused by chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. The ipratropium and albuterol inhaler contains a combination of two medications: ipratropium bromide (Atrovent®) and albuterol sulfate (Proair®, Proventil®, Ventolin®). The ipratropium and albuterol inhaler is approved for treating COPD in people who still have breathing problems after trying one of these medications.
In order to comply with the Montreal Protocol on Substances That Deplete the Ozone Layer, Combivent inhalers (in their original form) will not be available after July 2013 because they contain chlorofluorocarbons (CFCs), chemicals that deplete the ozone layer. A new formulation, Combivent Respimat, became available starting in October 2012. People using the old Combivent inhaler will need to get a new prescription in order to switch to the new Combivent Respimat inhaler.
(Click What Is Ipratropium and Albuterol Inhaler Used For? for more information, including possible off-label uses.)
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD